English | Español
Patient Daily | Feb 15, 2026

Penn Medicine study finds texts more effective than flyers for connecting ED patients to public benefits
Patient Daily | Feb 15, 2026

Tri City Rentals designates over 2,700 Rochester apartments as fully smoke-free
Patient Daily | Feb 14, 2026

Novo Nordisk sues Hims & Hers over compounded Wegovy amid industry earnings reports
Patient Daily | Feb 14, 2026

Madrigal partners with Suzhou Ribo Life Science on $4.4B siRNA liver disease programs
Patient Daily | Feb 14, 2026

Experts discuss role of AI in improving HER2 cancer diagnostics
Patient Daily | Feb 14, 2026

BioMarin acquires Amicus Therapeutics as competitors challenge key drug Voxzogo
Patient Daily | Feb 14, 2026

Osteoprotegerin identified as key link between bone health and heart disease
Patient Daily | Feb 14, 2026

Digital ad strategies help retailers boost measurable in-store sales

Trending
+ Pharmaceuticals
Patient Daily | Apr 5, 2026

Amplifon announces $2 billion acquisition of GN Hearing in strategic shift
Patient Daily | Apr 7, 2026

ProPublica examines impact of RFK Jr.'s vaccine policies on childhood disease risks
+ Pharmaceuticals
Patient Daily | Apr 1, 2026

Biopharma mergers and acquisitions reach $46.8 billion in first quarter of 2026
+ Regulatory
Patient Daily | Apr 8, 2026

Columbia University Professor Masia on 340B: '340B has become a drug mark-up program. Hospitals buy drugs at low cost and sell them high'